Categories Annual ReportsCorporate GovernanceDefault CalendarFeatured DocumentsPresentationsProxy Statements Year None2024202320222021202020192018201720162015201420132012201120102009200820072006 Title Supernus Announces First Quarter 2017 Financial Results Supernus to Host First Quarter 2017 Earnings Conference Call Supernus Receives Final FDA Approval for Trokendi XR® for Migraine Prophylaxis in Adults and Adolescents View Presentation Supernus Announces Settlement with Actavis on Trokendi XR® Patent Litigation Supernus Announces Settlement with Zydus on Trokendi XR® Patent Litigation Supernus Announces Record Fourth Quarter and Full Year 2016 Financial Results Supernus to Present at Cowen Health Care Conference in March Supernus to Host Fourth Quarter and Full Year 2016 Earnings Conference Call Supernus Announces Issuance of Eighth U.S. Patent Protecting Trokendi XR® Pagination First page « first Previous page ‹ previous … Page 3 Page 4 Page 5 Page 6 Current page 7 Page 8 Page 9 Page 10 Page 11 … Next page next › Last page last »